Cargando…
LogLoss-BERAF: An ensemble-based machine learning model for constructing highly accurate diagnostic sets of methylation sites accounting for heterogeneity in prostate cancer
Although modern methods of whole genome DNA methylation analysis have a wide range of applications, they are not suitable for clinical diagnostics due to their high cost and complexity and due to the large amount of sample DNA required for the analysis. Therefore, it is crucial to be able to identif...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214495/ https://www.ncbi.nlm.nih.gov/pubmed/30388122 http://dx.doi.org/10.1371/journal.pone.0204371 |
_version_ | 1783367979147198464 |
---|---|
author | Babalyan, K. Sultanov, R. Generozov, E. Sharova, E. Kostryukova, E. Larin, A. Kanygina, A. Govorun, V. Arapidi, G. |
author_facet | Babalyan, K. Sultanov, R. Generozov, E. Sharova, E. Kostryukova, E. Larin, A. Kanygina, A. Govorun, V. Arapidi, G. |
author_sort | Babalyan, K. |
collection | PubMed |
description | Although modern methods of whole genome DNA methylation analysis have a wide range of applications, they are not suitable for clinical diagnostics due to their high cost and complexity and due to the large amount of sample DNA required for the analysis. Therefore, it is crucial to be able to identify a relatively small number of methylation sites that provide high precision and sensitivity for the diagnosis of pathological states. We propose an algorithm for constructing limited subsamples from high-dimensional data to form diagnostic panels. We have developed a tool that utilizes different methods of selection to find an optimal, minimum necessary combination of factors using cross-entropy loss metrics (LogLoss) to identify a subset of methylation sites. We show that the algorithm can work effectively with different genome methylation patterns using ensemble-based machine learning methods. Algorithm efficiency, precision and robustness were evaluated using five genome-wide DNA methylation datasets (totaling 626 samples), and each dataset was classified into tumor and non-tumor samples. The algorithm produced an AUC of 0.97 (95% CI: 0.94–0.99, 9 sites) for prostate adenocarcinoma and an AUC of 1.0 (from 2 to 6 sites) for urothelial bladder carcinoma, two types of kidney carcinoma and colorectal carcinoma. For prostate adenocarcinoma we showed that identified differential variability methylation patterns distinguish cluster of samples with higher recurrence rate (hazard ratio for recurrence = 0.48, 95% CI: 0.05–0.92; log-rank test, p-value < 0.03). We also identified several clusters of correlated interchangeable methylation sites that can be used for the elaboration of biological interpretation of the resulting models and for further selection of the sites most suitable for designing diagnostic panels. LogLoss-BERAF is implemented as a standalone python code and open-source code is freely available from https://github.com/bioinformatics-IBCH/logloss-beraf along with the models described in this article. |
format | Online Article Text |
id | pubmed-6214495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-62144952018-11-19 LogLoss-BERAF: An ensemble-based machine learning model for constructing highly accurate diagnostic sets of methylation sites accounting for heterogeneity in prostate cancer Babalyan, K. Sultanov, R. Generozov, E. Sharova, E. Kostryukova, E. Larin, A. Kanygina, A. Govorun, V. Arapidi, G. PLoS One Research Article Although modern methods of whole genome DNA methylation analysis have a wide range of applications, they are not suitable for clinical diagnostics due to their high cost and complexity and due to the large amount of sample DNA required for the analysis. Therefore, it is crucial to be able to identify a relatively small number of methylation sites that provide high precision and sensitivity for the diagnosis of pathological states. We propose an algorithm for constructing limited subsamples from high-dimensional data to form diagnostic panels. We have developed a tool that utilizes different methods of selection to find an optimal, minimum necessary combination of factors using cross-entropy loss metrics (LogLoss) to identify a subset of methylation sites. We show that the algorithm can work effectively with different genome methylation patterns using ensemble-based machine learning methods. Algorithm efficiency, precision and robustness were evaluated using five genome-wide DNA methylation datasets (totaling 626 samples), and each dataset was classified into tumor and non-tumor samples. The algorithm produced an AUC of 0.97 (95% CI: 0.94–0.99, 9 sites) for prostate adenocarcinoma and an AUC of 1.0 (from 2 to 6 sites) for urothelial bladder carcinoma, two types of kidney carcinoma and colorectal carcinoma. For prostate adenocarcinoma we showed that identified differential variability methylation patterns distinguish cluster of samples with higher recurrence rate (hazard ratio for recurrence = 0.48, 95% CI: 0.05–0.92; log-rank test, p-value < 0.03). We also identified several clusters of correlated interchangeable methylation sites that can be used for the elaboration of biological interpretation of the resulting models and for further selection of the sites most suitable for designing diagnostic panels. LogLoss-BERAF is implemented as a standalone python code and open-source code is freely available from https://github.com/bioinformatics-IBCH/logloss-beraf along with the models described in this article. Public Library of Science 2018-11-02 /pmc/articles/PMC6214495/ /pubmed/30388122 http://dx.doi.org/10.1371/journal.pone.0204371 Text en © 2018 Babalyan et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Babalyan, K. Sultanov, R. Generozov, E. Sharova, E. Kostryukova, E. Larin, A. Kanygina, A. Govorun, V. Arapidi, G. LogLoss-BERAF: An ensemble-based machine learning model for constructing highly accurate diagnostic sets of methylation sites accounting for heterogeneity in prostate cancer |
title | LogLoss-BERAF: An ensemble-based machine learning model for constructing highly accurate diagnostic sets of methylation sites accounting for heterogeneity in prostate cancer |
title_full | LogLoss-BERAF: An ensemble-based machine learning model for constructing highly accurate diagnostic sets of methylation sites accounting for heterogeneity in prostate cancer |
title_fullStr | LogLoss-BERAF: An ensemble-based machine learning model for constructing highly accurate diagnostic sets of methylation sites accounting for heterogeneity in prostate cancer |
title_full_unstemmed | LogLoss-BERAF: An ensemble-based machine learning model for constructing highly accurate diagnostic sets of methylation sites accounting for heterogeneity in prostate cancer |
title_short | LogLoss-BERAF: An ensemble-based machine learning model for constructing highly accurate diagnostic sets of methylation sites accounting for heterogeneity in prostate cancer |
title_sort | logloss-beraf: an ensemble-based machine learning model for constructing highly accurate diagnostic sets of methylation sites accounting for heterogeneity in prostate cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214495/ https://www.ncbi.nlm.nih.gov/pubmed/30388122 http://dx.doi.org/10.1371/journal.pone.0204371 |
work_keys_str_mv | AT babalyank loglossberafanensemblebasedmachinelearningmodelforconstructinghighlyaccuratediagnosticsetsofmethylationsitesaccountingforheterogeneityinprostatecancer AT sultanovr loglossberafanensemblebasedmachinelearningmodelforconstructinghighlyaccuratediagnosticsetsofmethylationsitesaccountingforheterogeneityinprostatecancer AT generozove loglossberafanensemblebasedmachinelearningmodelforconstructinghighlyaccuratediagnosticsetsofmethylationsitesaccountingforheterogeneityinprostatecancer AT sharovae loglossberafanensemblebasedmachinelearningmodelforconstructinghighlyaccuratediagnosticsetsofmethylationsitesaccountingforheterogeneityinprostatecancer AT kostryukovae loglossberafanensemblebasedmachinelearningmodelforconstructinghighlyaccuratediagnosticsetsofmethylationsitesaccountingforheterogeneityinprostatecancer AT larina loglossberafanensemblebasedmachinelearningmodelforconstructinghighlyaccuratediagnosticsetsofmethylationsitesaccountingforheterogeneityinprostatecancer AT kanyginaa loglossberafanensemblebasedmachinelearningmodelforconstructinghighlyaccuratediagnosticsetsofmethylationsitesaccountingforheterogeneityinprostatecancer AT govorunv loglossberafanensemblebasedmachinelearningmodelforconstructinghighlyaccuratediagnosticsetsofmethylationsitesaccountingforheterogeneityinprostatecancer AT arapidig loglossberafanensemblebasedmachinelearningmodelforconstructinghighlyaccuratediagnosticsetsofmethylationsitesaccountingforheterogeneityinprostatecancer |